RecruitingNot ApplicableNCT03203239

Red Light Treatment in Peripheral Artery Disease

Vasodilatory Effects of Light on Peripheral Artery Disease


Sponsor

University of Alabama at Birmingham

Enrollment

40 participants

Start Date

Jan 17, 2018

Study Type

INTERVENTIONAL

Conditions

Summary

Subjects with a known diagnosis of peripheral artery disease as measured by an abnormal ankle brachial index (\<.9 or \>1.1) will undergo a single 5 min exposure of 670 nm light, 1 cm above the gastrocnemius muscle. Blood flow will be measured by infusion of ultrasound contrast and subsequent acquisition of ultrasound images. 2 blood samples will be collected for measurement of nitric oxide metabolites.


Eligibility

Min Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether red light therapy — using near-infrared light to stimulate blood vessel function — can improve blood flow and walking ability in patients with peripheral artery disease (PAD). PAD occurs when narrowed arteries reduce blood flow to the legs, causing cramping and pain during activity. This non-invasive approach may offer relief without surgery. You may be eligible if: - You are between 18 and 85 years old - You have been diagnosed with peripheral artery disease (PAD), confirmed by an ankle-brachial index below 0.9 or above 1.1 - You can understand the consent process - You can read and speak English You may NOT be eligible if: - You are pregnant - You have a known allergy to ultrasound contrast agents (perflutren) - You have pulmonary hypertension - You are using illicit drugs - You have uncontrolled high blood pressure (over 160/95) - You have sickle cell disease or a history of a heart hole (intracardiac shunt) - You have spinal stenosis, unspecified pain disorders, or uncontrolled medical conditions Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICERed Light (670 nm energy)

Light Emitting Diode light source (670 nm wavelength with output up to 75mW/cm2) will be placed over the gastrocnemius muscle. The light will be on for 5 minutes.

DRUGOctafluoropropane

All subjects will undergo infusion of octafluoropropane to measure peripheral blood flow.


Locations(1)

Medical College of Wisconsin

Milwaukee, Wisconsin, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03203239


Related Trials